The Swiss Anecova Selected
LAUSANNE, Switzerland, Nov. 29 /CNW/ - The World Economic Forum has
announced today the 39 visionary companies selected as Technology Pioneers
2008. Based in Lausanne, the Swiss company Anecova is one of them. The
Technology Pioneers 2008 were nominated by the world's leading technology
experts, including venture capitalists, technology companies, academics and
media. The final selection from 273 nominees was made by a panel of leading
technology experts appointed by the World Economic Forum. Anecova and
mondoBiotech are the first Swiss biotech companies selected as Technology
Pioneers. These Technology Pioneers 2008 are invited to participate in the
World Economic Forum Annual Meeting 2008 that will be held in Davos,
Switzerland, on 23-27 January and in the Annual Meeting of the New Champions
that will be held in Tianjin, People's Republic of China on 25-27 September
Anecova (http://www.anecova.com) is a leading life science company
focused on the development and commercialization of innovative technologies in
the field of medically assisted procreation. Anecova's aim is to improve
results and the overall quality of care thanks to more physiological and
natural processes. The first Anecova product restores the fertilization and
early embryonic development phases back into the physiologic environment of
the maternal uterus instead of in a laboratory incubator. This allows the
development of the embryos to take place in close communication and exchange
with maternal factors from the very start of life.
The preliminary results already obtained have been very encouraging.
Anecova is currently undertaking clinical evaluation programs in close
collaboration with international experts in the field, pursuing its quest for
medical solutions of the highest quality for patients worldwide.
"We are honoured to have been selected as a Technology Pioneer for 2008
as a result of our research for a more natural approach to improve medically
assisted procreation," said Martin Velasco, Founder, Chairman and CEO. "This
award further motivates us to continue to work in the development of
innovative Assisted Reproductive Technology (ART) solutions adding value to
society at large."
"We would like to associate to this Award Prof. Patrick Aebischer (EPFL),
Prof. Carlos Simon (IVI-Valencia) and Prof. Paul Devroey (VUB-Belgium) and
their teams for their valuable contribution," added Martin Velasco.
Technology Pioneers are companies that have been identified as developing
and applying highly transformational and innovative technologies in the areas
of energy, biotechnology and health, and information technology. To be
selected as a Technology Pioneer, a company must be involved in the
development of life-changing technology innovation and have the potential for
long-term impact on business and society. In addition, it must demonstrate
visionary leadership, show all the signs of being a long-standing market
leader - and its technology must be proven.
Previous Technology Pioneers have included Business Objects, Cambridge
Silicon Radio, Corel Corporation, Encore Software, Google, Mozilla Corporation
Twenty-three of the Technology Pioneers 2008 are US-based companies.
Israel and the United Kingdom each boast three; Sweden and Switzerland two
each; Canada, France, Germany, India, the Netherlands and Russia, one each.
Technology Pioneers are nominated in three main categories:
Energy/Environment, Biotechnology/Health and Information Technology.
The entire list of Technology Pioneers and interviews with the CEOs of
the selected companies can be found on:
"This year the World Economic Forum received a record number of
applications from companies around the world to become a Technology Pioneer.
In a highly competitive field, we are extremely pleased to have a community
that uses innovation and technology to dramatically affect the way society and
business operate and to do so in a markedly collaborative manner. We are
excited to welcome the Technology Pioneers class of 2008 to the larger
community of the World Economic Forum and we are looking forward to the fruits
that their collaboration will bring," said Peter Torreele, Managing Director
of the World Economic Forum.
Anecova was created in 2004 by Martin Velasco and Dr Pascal Mock. The
company is based at the Parc Scientifique of the Ecole Polytechnique Federale
in Lausanne (Switzerland). Anecova is working with world leading scientists
and clinicians in the area of Assisted Reproductive Technology (ART) with the
objective of developing more natural approaches. The company obtained the
European Certification (CE Mark) in 2007 and expects to start
commercialisation in Europe within the second half of 2008.
About the World Economic Forum
The World Economic Forum is an independent international organization
committed to improving the state of the world by engaging leaders in
partnerships to shape global, regional and industry agendas.
Incorporated as a foundation in 1971, and based in Geneva, Switzerland,
the World Economic Forum is impartial and a non-profit organization; it is
tied to neither political, partisan nor national interests.
For further information:
For further information: Martin Velasco, CEO Anecova, Tel:
+41-22-310-95-42, Internet: http://www.anecova.com